Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

FDA grants Regenerative Medicine Advanced Therapy designation to Direct Biologics’ extracellular vesicle drug for Covid-19

Direct Biologics, an innovative biotechnology company with a groundbreaking extracellular vesicle (EV) platform drug technology, announced that the U.S. Food and Drug Administration has...

BioNTech plans to advance new formulations for mRNA vaccines in new research collaboration

BioNTech SE and Matinas BioPharma, a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid...

RedHill reports powerful inhibition of Omicron SARS-CoV-2 variant by the oral drug candidate

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced study results in which opaganib, a leading oral drug candidate for hospitalized patients with moderate to...

GSK expands oncology product line by acquiring Sierra Oncology for $1.9 billion

GlaxoSmithKline plc and Sierra Oncology, Inc April 13th announced that the companies have entered into an agreement under which GSK will acquire Sierra Oncology,...

Engitix and Takeda expand collaboration in antifibrotic therapy

Engitix Ltd., a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, April...

FDA partially suspends study of Curis’ lymphoma drug

Curis, Inc., a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, April 11th announced that the U.S. Food...
spot_img

Expert Articles

spot_img